Eton Pharmaceuticals Inc
NASDAQ:ETON
Eton Pharmaceuticals Inc
NASDAQ:ETON
Price:
26.36
USD
-2.73%
Market Closed
Market Cap:
$707m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Eton Pharmaceuticals Inc
NASDAQ:ETON
|
US |
|
Senco Gold Ltd
BSE:543936
|
IN |
|
Tosei Reit Investment Corp
TSE:3451
|
JP |
|
Kafein Yazilim Hizmetleri Ticaret AS
IST:KFEIN.E
|
TR |
|
C
|
Capital Asset Planning Inc
TSE:3965
|
JP |
Income Statement
Earnings Waterfall
Eton Pharmaceuticals Inc
Eton Pharmaceuticals Inc
Income Statement
Eton Pharmaceuticals Inc
Eton Pharmaceuticals Inc
Currency: USD
| Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||||||||||||||||||||
| Interest Expense |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
1
|
2
|
3
|
4
|
5
|
5
|
|
| Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
1
N/A
|
1
N/A
|
1
N/A
|
1
+92%
|
1
-42%
|
1
+4%
|
0
-28%
|
0
-90%
|
12
+29 500%
|
15
+26%
|
16
+6%
|
22
+38%
|
12
-44%
|
16
+35%
|
19
+15%
|
21
+13%
|
24
+15%
|
29
+19%
|
33
+13%
|
32
-4%
|
34
+8%
|
31
-9%
|
35
+10%
|
39
+12%
|
48
+24%
|
58
+20%
|
70
+21%
|
80
+14%
|
|
| Gross Profit | ||||||||||||||||||||||||||||||||
| Cost of Revenue |
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
0
|
(0)
|
(2)
|
(2)
|
(3)
|
(3)
|
(2)
|
(5)
|
(5)
|
(7)
|
(8)
|
(8)
|
(9)
|
(11)
|
(12)
|
(13)
|
(14)
|
(16)
|
(20)
|
(24)
|
(34)
|
(37)
|
|
| Gross Profit |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
1
N/A
|
0
N/A
|
(0)
N/A
|
(0)
-200%
|
(0)
-733%
|
10
N/A
|
13
+29%
|
13
+1%
|
19
+45%
|
10
-47%
|
12
+17%
|
14
+16%
|
14
+5%
|
16
+14%
|
21
+31%
|
24
+11%
|
21
-11%
|
23
+8%
|
19
-18%
|
21
+10%
|
23
+14%
|
28
+21%
|
35
+22%
|
36
+4%
|
43
+18%
|
|
| Operating Income | ||||||||||||||||||||||||||||||||
| Operating Expenses |
(11)
|
(10)
|
(10)
|
(15)
|
(16)
|
(19)
|
(19)
|
(20)
|
(22)
|
(23)
|
(27)
|
(23)
|
(24)
|
(23)
|
(21)
|
(25)
|
(26)
|
(25)
|
(23)
|
(25)
|
(25)
|
(25)
|
(22)
|
(22)
|
(25)
|
(26)
|
(26)
|
(31)
|
(35)
|
(39)
|
(43)
|
|
| Selling, General & Administrative |
(5)
|
(5)
|
(5)
|
(5)
|
(6)
|
(6)
|
(8)
|
(9)
|
(10)
|
(12)
|
(13)
|
(14)
|
(15)
|
(14)
|
(14)
|
(15)
|
(17)
|
(18)
|
(19)
|
(19)
|
(19)
|
(19)
|
(19)
|
(19)
|
(20)
|
(21)
|
(22)
|
(26)
|
(30)
|
(33)
|
(35)
|
|
| Research & Development |
(5)
|
(5)
|
(6)
|
(11)
|
(11)
|
(12)
|
(12)
|
(11)
|
(12)
|
(11)
|
(14)
|
(9)
|
(9)
|
(9)
|
(6)
|
(10)
|
(9)
|
(7)
|
(4)
|
(6)
|
(7)
|
(7)
|
(3)
|
(3)
|
(5)
|
(5)
|
(3)
|
(5)
|
(5)
|
(6)
|
(8)
|
|
| Other Operating Expenses |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
|
| Operating Income |
(11)
N/A
|
(10)
+4%
|
(10)
-1%
|
(15)
-44%
|
(16)
-4%
|
(18)
-17%
|
(19)
-2%
|
(20)
-7%
|
(21)
-6%
|
(22)
-6%
|
(27)
-21%
|
(13)
+53%
|
(11)
+17%
|
(10)
+4%
|
(2)
+85%
|
(15)
-873%
|
(14)
+4%
|
(11)
+21%
|
(9)
+21%
|
(9)
-3%
|
(4)
+58%
|
(1)
+62%
|
(1)
+18%
|
1
N/A
|
(6)
N/A
|
(5)
+17%
|
(2)
+58%
|
(2)
-4%
|
(1)
+64%
|
(3)
-232%
|
(0)
+90%
|
|
| Pre-Tax Income | ||||||||||||||||||||||||||||||||
| Interest Income Expense |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
1
|
1
|
1
|
1
|
(1)
|
(2)
|
(3)
|
(4)
|
(4)
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
(1)
|
|
| Gain/Loss on Disposition of Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Other Income |
(1)
|
(1)
|
(3)
|
(3)
|
(2)
|
(2)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
3
|
3
|
0
|
3
|
4
|
4
|
0
|
0
|
(1)
|
(1)
|
0
|
0
|
0
|
0
|
0
|
|
| Pre-Tax Income |
(11)
N/A
|
(11)
-1%
|
(13)
-14%
|
(17)
-34%
|
(17)
-1%
|
(19)
-12%
|
(18)
+5%
|
(20)
-9%
|
(21)
-7%
|
(23)
-7%
|
(28)
-22%
|
(14)
+51%
|
(11)
+20%
|
(11)
+4%
|
(2)
+82%
|
(12)
-533%
|
(12)
+4%
|
(9)
+25%
|
(9)
-1%
|
(6)
+29%
|
(0)
+96%
|
2
N/A
|
(1)
N/A
|
1
N/A
|
(6)
N/A
|
(5)
+17%
|
(4)
+28%
|
(4)
-18%
|
(4)
+10%
|
(6)
-61%
|
(5)
+30%
|
|
| Net Income | ||||||||||||||||||||||||||||||||
| Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Income from Continuing Operations |
(11)
|
(11)
|
(13)
|
(17)
|
(17)
|
(19)
|
(18)
|
(20)
|
(21)
|
(23)
|
(28)
|
(14)
|
(11)
|
(11)
|
(2)
|
(12)
|
(12)
|
(9)
|
(9)
|
(6)
|
(0)
|
2
|
(1)
|
1
|
(7)
|
(5)
|
(4)
|
(5)
|
(4)
|
(7)
|
(5)
|
|
| Net Income (Common) |
(14)
N/A
|
(14)
-1%
|
(37)
-165%
|
(41)
-10%
|
(40)
+1%
|
(42)
-3%
|
(18)
+56%
|
(20)
-9%
|
(21)
-7%
|
(23)
-7%
|
(28)
-22%
|
(14)
+51%
|
(11)
+20%
|
(11)
+4%
|
(2)
+82%
|
(12)
-533%
|
(12)
+4%
|
(9)
+25%
|
(9)
-1%
|
(6)
+29%
|
(0)
+96%
|
2
N/A
|
(1)
N/A
|
1
N/A
|
(7)
N/A
|
(5)
+18%
|
(4)
+30%
|
(5)
-20%
|
(4)
+10%
|
(7)
-62%
|
(5)
+31%
|
|
| EPS (Diluted) |
-0.85
N/A
|
-0.86
-1%
|
-2.11
-145%
|
-2.35
-11%
|
-2.27
+3%
|
-2.33
-3%
|
-1.03
+56%
|
-1.11
-8%
|
-1.02
+8%
|
-1.09
-7%
|
-1.33
-22%
|
-0.51
+62%
|
-0.43
+16%
|
-0.42
+2%
|
-0.08
+81%
|
-0.49
-513%
|
-0.47
+4%
|
-0.35
+26%
|
-0.36
-3%
|
-0.24
+33%
|
0
N/A
|
0.1
N/A
|
-0.04
N/A
|
0.04
N/A
|
-0.26
N/A
|
-0.21
+19%
|
-0.15
+29%
|
-0.18
-20%
|
-0.15
+17%
|
-0.25
-67%
|
-0.17
+32%
|
|
Switch to:
Switch to:
See Also
Discover More
